
A look at Aurinia Pharmaceuticals Inc’s (AUPH) recent performance gives investors their first glimpse of hope.
On Tuesday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was -11.69% drop from the session before settling in for the closing price of $8.47. A 52-week range